TR Biofab Financials
| 246710 Stock | KRW 5,920 40.00 0.67% |
246710 |
Understanding current and past TR Biofab Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of TR Biofab's financial statements are interrelated, with each one affecting the others. For example, an increase in TR Biofab's assets may result in an increase in income on the income statement.
Please note, the presentation of TR Biofab's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, TR Biofab's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of TR Biofab's management manipulating its earnings.
TR Biofab Stock Summary
TR Biofab competes with Korea Information, Union Materials, Home Center, Cuckoo Homesys, and Polaris Office. TR Biofab Co., Ltd. researches and develops medical devices for transplantation and tissue regeneration in the areas of orthopedics, plastic surgery, and dentistry. The company was founded in 2013 and is based in Siheung, South Korea. TR Biofab is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7246710008 |
| Business Address | 237, Sangidaehak-ro, Siheung, |
| Sector | Healthcare |
| Industry | Health Care Equipment & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | www.tnrbiofab.com |
| Phone | 82 3 1431 3344 |
| Currency | KRW - South Korean Won |
You should never invest in TR Biofab without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of 246710 Stock, because this is throwing your money away. Analyzing the key information contained in TR Biofab's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
TR Biofab Key Financial Ratios
TR Biofab's financial ratios allow both analysts and investors to convert raw data from TR Biofab's financial statements into concise, actionable information that can be used to evaluate the performance of TR Biofab over time and compare it to other companies across industries.| Return On Equity | -36.36 | |||
| Return On Asset | -0.098 | |||
| Beta | 0.48 | |||
| Z Score | 1.8 |
246710 Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining TR Biofab's current stock value. Our valuation model uses many indicators to compare TR Biofab value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across TR Biofab competition to find correlations between indicators driving TR Biofab's intrinsic value. More Info.TR Biofab Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value TR Biofab by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for TR Biofab's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.TR Biofab Systematic Risk
TR Biofab's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. TR Biofab volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was four with a total number of output elements of fifty-seven. The Beta measures systematic risk based on how returns on TR Biofab correlated with the market. If Beta is less than 0 TR Biofab generally moves in the opposite direction as compared to the market. If TR Biofab Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one TR Biofab is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of TR Biofab is generally in the same direction as the market. If Beta > 1 TR Biofab moves generally in the same direction as, but more than the movement of the benchmark.
TR Biofab November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of TR Biofab help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of TR Biofab Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of TR Biofab Co based on widely used predictive technical indicators. In general, we focus on analyzing 246710 Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build TR Biofab's daily price indicators and compare them against related drivers.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 16.21 | |||
| Value At Risk | (4.24) | |||
| Potential Upside | 4.27 |
Complementary Tools for 246710 Stock analysis
When running TR Biofab's price analysis, check to measure TR Biofab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TR Biofab is operating at the current time. Most of TR Biofab's value examination focuses on studying past and present price action to predict the probability of TR Biofab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TR Biofab's price. Additionally, you may evaluate how the addition of TR Biofab to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |